An Open Label Trial to Evaluate the Effects of a Novel Renal Multivitamin on Inflammation and Other Biomarkers in Endstage Renal Disease Patients

PHASE2UnknownINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
HyperphosphatemiaInflammationRenal Disease
Interventions
DIETARY_SUPPLEMENT

Oral Multivitamin

Oral Multivitamin

Trial Locations (1)

93063

RECRUITING

Simi Valley Dialysis Center, Simi Valley

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Nephrian

INDUSTRY